How P2P Improves Procurement Efficiency in Life Sciences | ZAGENO

Biotech and pharma teams are under constant pressure to move faster without increasing headcount, yet many procurement workflows still rely on disconnected systems for purchasing, accounts payable, supplier management, and order tracking.

Procure-to-pay (P2P) automation brings these functions into a single workflow, reducing manual effort and improving visibility across the entire purchasing process. For a full breakdown of the procure-to-pay workflow in life sciences, see our guide.

6 ways procure-to-pay improves efficiency in biotech and pharma

What improved efficiency means for lab teams

For biotech and pharma teams, procurement efficiency is not just an operational metric. It directly impacts how quickly experiments can move forward and how much time scientists spend on non-scientific tasks.

By reducing delays in ordering, approvals, and supplier communication, P2P automation allows research teams to stay focused on execution rather than administration. Over time, these efficiency gains compound; shortening timelines, improving coordination, and supporting more predictable lab operations.

In Part 2, we look at how P2P automation reduces costs and improves financial control across procurement workflows.

FAQs about P2P efficiency in life sciences

1. How does P2P improve procurement efficiency?
   P2P improves efficiency by automating purchasing workflows, reducing manual approvals, and centralizing supplier and order data. This shortens cycle times and reduces administrative overhead.
2. What processes are streamlined with P2P automation?
   P2P streamlines purchase requisitions, approvals, purchase order creation, invoice matching, and supplier communication within a single workflow.
3. Why is procurement efficiency critical in biotech and pharma?
   Procurement delays can slow down experiments and disrupt timelines. Efficient workflows ensure that researchers receive the materials they need without unnecessary delays.